Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Change in Accured Expenses (2016 - 2019)

Historic Change in Accured Expenses for Soleno Therapeutics (SLNO) over the last 7 years, with Q4 2019 value amounting to $968000.0.

  • Soleno Therapeutics' Change in Accured Expenses rose 52857.14% to $968000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.7 million, marking a year-over-year increase of 42305.3%. This contributed to the annual value of $1.6 million for FY2024, which is 1239.73% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Change in Accured Expenses of $968000.0 as of Q4 2019, which was up 52857.14% from $442000.0 recorded in Q3 2019.
  • Over the past 5 years, Soleno Therapeutics' Change in Accured Expenses peaked at $968000.0 during Q4 2019, and registered a low of -$317000.0 during Q1 2016.
  • Moreover, its 5-year median value for Change in Accured Expenses was $147500.0 (2018), whereas its average is $182205.6.
  • Within the past 5 years, the most significant YoY rise in Soleno Therapeutics' Change in Accured Expenses was 395000.0% (2018), while the steepest drop was 41428.57% (2018).
  • Over the past 5 years, Soleno Therapeutics' Change in Accured Expenses (Quarter) stood at $467626.0 in 2015, then skyrocketed by 49.8% to $700486.0 in 2016, then tumbled by 100.57% to -$4000.0 in 2017, then skyrocketed by 3950.0% to $154000.0 in 2018, then soared by 528.57% to $968000.0 in 2019.
  • Its Change in Accured Expenses stands at $968000.0 for Q4 2019, versus $442000.0 for Q3 2019 and $81000.0 for Q2 2019.